Barley kernel based products have been shown to induce benefits on blood glucose regulation, cardio-metabolic risk markers and appetite regulating hormones in a time perspective of 11 16 h after intake.
Although various calcium silicate based products have been launched to the market recently, one of these has especially been the focus of attention and the topic of a variety of investigations.
A driving force for production of many bio-based products has been a search for alternatives to fossil fuels, which have been subject to price volatility affecting the profit margins of downstream products.
However, the progress in regenerative medicine, especially in stem cell-based products, has been fairly modest, as it is fairly commonly seen that there ought to be clear evidence from phase II clinical trials before even pursuing the commercialisation phase (Parson 2008).
Dietary intake of tomatoes and tomato-based products has been associated with a reduced incidence of developing atherosclerosis, coronary heart disease and prostate cancer [1] [4].
A ban on manufacturing, importing, exporting, and selling of baby bottles made of BPA-based products has been approved by the National Assembly on 11th May 2010.
The extensive antileishmanial potential of plant and marine based natural products has been previously reviewed in the literature.
On the other hand, the use of absorbents based on natural products has been growing in recent years.
To demonstrate the merit of unique structure for the fast mass transfer, sensor based on SnO2 products has been fabricated and the results exhibit excellent sensing performances for toluene detection.
The digestion of the PCR products with the restriction enzyme BstEII allowed the easy discrimination between "a" and "b" subtypes The diagnostic system based on PCR products has been tested on seventeen isolates and references strains, however before considering the general applicability of this assay it will be necessary to analyze more samples of all BoHV-5 subtypes.
A water based combination of 0.1% octenidine dihydrochloride and 2% 2 - phenoxyethanol is registered in many European countries as an antiseptic solution (octenisept®) for topical treatment with high antimicrobial activity for human use, but octenidine based products have not been registered for veterinary use yet.
